Propanc Biopharma, Inc Common Stock (PPCB) | Q1 2025 | 916,566.67% |
Diginex Limited Ordinary Shares (DGNX) | Q1 2025 | 1,982.16% |
Eva Live Inc Common Stock (GOAI) | Q1 2025 | 1,045.39% |
Briacell Therapeutics (BCTX) | Q1 2025 | 540.9% |
Regencell Bioscience (RGC) | Q1 2025 | 527.45% |
MicroAlgo (MLGO) | Q1 2025 | 419.27% |
Abits (ABTS) | Q1 2025 | 372.53% |
Dominari (DOMH) | Q1 2025 | 324.75% |
Lixiang Education (LXEH) | Q1 2025 | 287.4% |
CervoMed (CRVO) | Q1 2025 | 281.25% |
Jiuzi (JZXN) | Q1 2025 | 227.86% |
Rapid Micro Biosystems (RPID) | Q1 2025 | 190.11% |
SuperX AI Technology (SUPX) | Q1 2025 | 147.86% |
Almonty Industries Inc Common Shares (ALM) | Q1 2025 | 145.31% |
Oriental Culture Holding (OCG) | Q1 2025 | 142.86% |
Palvella Therapeutics (PVLA) | Q1 2025 | 141.09% |
Jayud Global Logistics Limited Class A Ordinary Shares (JYD) | Q1 2025 | 136.62% |
Niu Technologies (NIU) | Q1 2025 | 126.67% |
Corcept Therapeutics (CORT) | Q1 2025 | 125.64% |
Park Ha Biological Technology (BYAH) | Q1 2025 | 124.83% |
Neuronetics (STIM) | Q1 2025 | 123.03% |
Xunlei Ltd Adr (XNET) | Q1 2025 | 120.1% |
Jiayin (JFIN) | Q1 2025 | 118.44% |
Reborn Coffee (REBN) | Q1 2025 | 115.79% |
MyseumAI (MYSE) | Q1 2025 | 113.26% |